Stay updated on SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial
Sign up to get notified when there's something new on the SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial page.

Latest updates to the SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision label updated to v3.5.4, indicating a new version of the page. The change reflects an incremental update to the page metadata rather than substantive content changes.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedUpdated the site’s revision/version indicator from **v3.5.0** to **v3.5.3**, reflecting a maintenance or release update rather than a change to the clinical trial record.SummaryDifference0.1%

- Check69 days agoChange DetectedUpdated the site revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3. It appears to be an internal version update and does not alter the study details or page content.SummaryDifference0.1%

- Check105 days agoChange DetectedThe page revision updated to v3.4.2 from v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check112 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 with no visible changes to study content, eligibility criteria, or results; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial page.